|
⚲
|
| Keyboard |
| Daly James M
✚
|
|
|---|---|
| CIK # | 0001560782 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001560782] | |
| 4 | [0001560782] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Daly James M | |
| Madrigal Pharmaceuticals Inc | |
| Acadia Pharmaceuticals Inc | |
| Cytokinetics Inc | |
| Halozyme Therapeutics Inc | |
| Bellicum Pharmaceuticals Inc | |
| Chimerix Inc | |
| Incyte Corp |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cytokinetics Inc CYTK
Common Stock
|
2026-01-15 | Grant | 197 | $63.44 | 12,498 |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2025-11-10 | Sell | 30,000 | $22.37 | 671,100 |
|
Cytokinetics Inc CYTK
Non-Qualified Stock Option (Right to Buy) · derivative
|
2025-08-19 | Grant | 27,450 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2025-06-20 | Grant | 715 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 1,290 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2025-05-29 | Option exercise | 9,387 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2025-05-29 | Grant | 8,107 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Director Stock Options (Right to Buy) · derivative
|
2025-05-29 | Grant | 13,793 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Common Stock
|
2025-05-29 | Option exercise | 9,387 | ||
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2025-02-27 | Sell | 398 | $346.90 | 138,066 |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2025-02-27 | Option exercise | 6,000 | $111.06 | 666,360 |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2025-02-27 | Option exercise | 9,470 | $65.06 | 616,118 |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2025-02-27 | Option exercise | 9,470 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2025-02-27 | Option exercise | 6,000 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2025-02-27 | Sell | 770 | $348.94 | 268,684 |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2025-02-27 | Sell | 14,302 | $347.39 | 4,968,372 |
|
Madrigal Pharmaceuticals Inc MDGL
Stock Option (Right to Buy) · derivative
|
2024-06-25 | Grant | 1,105 | $0.00 | |
|
Madrigal Pharmaceuticals Inc MDGL
Common Stock
|
2024-06-25 | Grant | 714 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Director Stock Options (Right to Buy) · derivative
|
2024-05-29 | Grant | 15,959 | $0.00 | |
|
Acadia Pharmaceuticals Inc ACAD
Restricted Stock Units · derivative
|
2024-05-29 | Option exercise | 6,652 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||